Treatment-Resistant Depression Treatment

When depression continues to interfere with daily life despite appropriate treatment, it does not mean that you are out of options. At Insight Choices, care begins with a comprehensive psychiatric evaluation to review the diagnosis, prior medications and treatment response, side effects, co-occurring conditions, and factors that may be affecting recovery. Your care plan may include medication management, psychotherapy, and an evaluation for Transcranial Magnetic Stimulation (TMS) when clinically appropriate.

Insight Choices offers in-person and telepsychiatry options for patients in California. TMS is an in-person treatment; availability and candidacy must be confirmed by the clinical team.

Start New Patient Registration Request a TMS Assessment

What Is Treatment-Resistant Depression?

Treatment-resistant depression (TRD) does not mean that depression is untreatable. The term is commonly used when a person with major depressive disorder has not improved enough despite adequate treatment.

In clinical practice, TRD commonly refers to major depressive disorder that has not improved sufficiently after at least two appropriately selected antidepressant trials given at adequate doses and for adequate durations. Definitions can vary across clinical guidelines, research studies, and insurance criteria. For that reason, trying two medications without adequate improvement does not automatically establish TRD. A clinician should review the diagnosis, medications, dose, duration, adherence, side effects, and actual response before applying the label.

Why Might Depression Not Improve With Treatment?

An incomplete response does not necessarily mean that depression is impossible to treat. Before considering TRD, it is important to reassess factors such as:

Whether the original diagnosis is complete and whether bipolar disorder or another mental health condition should be evaluated.

Whether prior medications were used at an adequate dose and for an adequate length of time.

Whether side effects, missed doses, or other barriers prevented a full treatment trial.

Whether anxiety, trauma-related symptoms, ADHD, substance use, sleep problems, or other psychiatric conditions are also present.

Whether medical conditions, other medications, or health factors could be affecting mood or treatment response.

Whether ongoing work, family, relationship, sleep, or chronic stress factors are continuing to worsen symptoms or functioning.

This is why an Insight Choices evaluation looks at the full treatment history rather than only the number of medications a patient has tried.

When Should You Consider a New Psychiatric Evaluation?

If you are being treated for depression, it may be time to review your treatment plan with a psychiatric professional when:

You have tried one or more treatments, but low mood, loss of interest, fatigue, sleep problems, or concentration difficulties continue.

Medication has helped somewhat, but symptoms still interfere with work, school, relationships, or daily functioning.

Medication side effects make it difficult to continue your current treatment.

You have changed medications several times without a clear review of whether each trial was adequate.

Your symptom pattern has changed—for example, periods of unusually high energy, markedly reduced need for sleep, or impulsive behavior—making diagnostic reassessment important.

You want to understand whether other evidence-based treatment options may be appropriate.

Important Safety Information

If you are having thoughts of suicide, harming yourself or someone else, or you cannot keep yourself safe, call 911 or go to the nearest emergency department. In the United States, you can also call or text 988 to reach the 988 Suicide & Crisis Lifeline for 24/7 crisis support.

How Does Insight Choices Evaluate Treatment-Resistant Depression?

The next step in TRD care should not be based on simply “trying another medication.” A psychiatric evaluation at Insight Choices may review:

Current depressive symptoms, severity, and impact on daily functioning.

Previous antidepressants, doses, treatment duration, benefits, and side effects.

Past psychotherapy and other treatment experiences.

Possible co-occurring conditions such as anxiety, bipolar disorder, ADHD, PTSD, substance use, or insomnia.

Medical history, other medications, sleep, life stressors, and support systems.

Suicide risk or other safety concerns that need immediate attention.

Your treatment goals, preferences, and the approaches you are comfortable considering.

Standardized symptom rating scales may also be used during intake and follow-up to help track changes over time and guide treatment decisions.

How Is Treatment-Resistant Depression Treated?

There is no single treatment that is right for everyone with TRD. The treatment plan should be individualized based on prior treatment history, symptom severity, co-occurring conditions, medical factors, side effects, preferences, and safety considerations.

Medication Management

A psychiatric clinician may first determine whether previous medication trials were adequate, then consider options such as dose optimization, switching antidepressants, or adding another medication as an augmentation strategy when appropriate. Medication changes should always be made with a qualified health care professional who can review your medical history and risks. Do not stop, add, or change medication doses on your own.

Psychotherapy

Psychotherapy can remain an important part of a comprehensive TRD treatment plan, particularly when patterns of thinking, stress, relationship difficulties, trauma, sleep problems, or behaviors continue to affect symptoms. The type and frequency of therapy

Transcranial Magnetic Stimulation (TMS)

TMS is a noninvasive brain stimulation treatment that uses magnetic pulses to stimulate specific areas of the brain and does not require general anesthesia. The FDA has cleared multiple TMS devices for specific major depressive disorder indications. For some patients who have not improved adequately with antidepressant treatment or who have difficulty tolerating medication side effects, TMS may be an option worth evaluating.
TMS candidacy should be determined by a qualified clinician who reviews the diagnosis, prior treatment response, current medications, seizure or other neurologic history, and safety considerations such as implanted or metallic medical devices. Treatment schedules, benefits, and side effects vary by person, and no specific outcome can be guaranteed.

Ongoing Monitoring and Treatment Adjustment

TRD often requires ongoing reassessment rather than a one-time decision. The clinical team can adjust the plan over time based on symptom changes, functional improvement, side effects, safety, and personal goals. Some patients may also need discussion of other advanced treatments or referral to a different level of care.

Is TMS Right for Everyone With Treatment-Resistant Depression?

No. TMS candidacy requires an individualized evaluation. The clinical team will typically consider the diagnosis of major depressive disorder, prior treatment response, medication tolerability, neurologic history, implanted devices, and other safety factors. If TMS is not the best option at this time, your clinician can discuss other treatment directions.

TMS is delivered in person and cannot be completed through telehealth. Psychiatric evaluation and some follow-up care may be available in person or by telepsychiatry depending on the patient’s location, clinical needs, applicable requirements, and service availability.

Why Choose Insight Choices for TRD Care?

Comprehensive psychiatric evaluation that considers diagnosis, symptoms, treatment history, medical factors, and daily functioning.

Individualized medication management with ongoing review of benefits and side effects.

Multiple treatment modalities, including psychiatric care, psychotherapy, and TMS when clinically appropriate.

Progress monitoring using clinical follow-up and, when appropriate, standardized rating scales.

California care options, including in-person and eligible telepsychiatry services; TMS is provided in person at locations offering the service.

Frequently Asked Questions

If two antidepressants did not work, does that mean I have treatment-resistant depression?

Not necessarily. Clinicians typically review whether the medications were appropriate and used at adequate doses for adequate durations. They may also reassess the diagnosis, adherence, co-occurring conditions, medical factors, and other reasons treatment response may have been limited.

Is treatment-resistant depression the same as major depressive disorder?

Not exactly. Major depressive disorder is a psychiatric diagnosis. Treatment-resistant depression generally describes an inadequate treatment response in a person with major depressive disorder after multiple appropriate treatment attempts.

Does everyone with treatment-resistant depression need TMS?

No. TMS is one potential treatment option, but it is not appropriate for everyone. The decision should be based on the diagnosis, prior treatments, medication tolerability, safety factors, and patient preferences.

Can I take antidepressant medication while receiving TMS?

Whether you continue, change, or combine medications during a course of TMS depends on the treatment protocol and your individual clinical situation. Your treating clinician should make that decision. Do not stop or change medication doses on your own.

How quickly does TMS work?

Response time and degree of improvement vary. Some people notice changes during the treatment course, while others need more sessions before response can be assessed. Progress should be monitored clinically and with symptom measures when appropriate. No specific timeline or outcome should be guaranteed.

Can treatment-resistant depression be treated through telepsychiatry?

For eligible patients in California, psychiatric evaluation and medication management may be available through telepsychiatry. TMS itself must be delivered in person at a location that provides the treatment. Availability depends on clinical needs and current services.

Ready to Revisit Your Depression Treatment Plan?

If you have tried depression treatment and still have not improved enough, the next step does not have to be another cycle of medication changes without a clear review. A comprehensive psychiatric reevaluation can help determine whether previous treatments were adequate, whether the diagnosis or co-occurring conditions need another look, and which evidence-based options may fit your needs.

Start New Patient Registration Request a TMS Assessment

Medical Review and YMYL Publishing Fields

Medically Reviewed by: [Clinician Name, Degree/Credentials]
Last Medically Reviewed: [To be completed by the clinical team before publication]
Medical Disclaimer: This page is for general health education and informational purposes only. It does not provide a diagnosis or individualized medical advice, establish a clinician-patient relationship, or replace evaluation by a qualified health care professional. Treatment choices, indications, contraindications, risks, and potential benefits vary by individual.

References

National Institute of Mental Health (NIMH) — Depression
National Institute of Mental Health (NIMH) — Brain Stimulation Therapies
VA/DoD Clinical Practice Guideline — Management of Major Depressive Disorder
U.S. Food and Drug Administration (FDA) — Repetitive Transcranial Magnetic Stimulation Systems
SAMHSA — 988 Suicide & Crisis Lifeline FAQ